product Image
DiaPlexC™ M.Avium/M.Intracellulare Detection Kit (Tuberculosis)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125210
Product Name
DiaPlexC™ M.Avium/M.Intracellulare Detection Kit (Tuberculosis)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexC™ M.Avium/M.Intracellulare Detection Kit

Multiplex PCR based assay system for simultaneous detection of M. avium and M. intracellulare among NTM complex


Mycobacterium avium and Mycobacterium intracellulare complex (MAC) is the atypical mycobacterium most commonly associated with human disease. MAC is primarily a pulmonary pathogen that affects individuals whose immune systems have been compromised (e.g. from AIDS, hairy cell leukemia, immunosuppressive chemotherapy). In this clinical setting, MAC has been associated with osteomyelitis, tenosynovitis and synovitis. MAC comprises two genetically distinct but Difficult to discriminate species. M. avium predominates (87 % - 98 %) in AIDS patients with no anti-retroviral therapy and M. intracellulare is more frequent among non-AIDS patients.




Specification


DiaPlexC™ M.Avium/M.Intracellulare Detection Kit
Detection targetMycobacterium avium , Mycobacterium intracellulare
RegistrationCE-IVD
Detection technologyConventional (End-point) Multiplex PCR
Specimen typeSputum, Bronchial lavage, Lung biopsy, Gastric lavage, Urine, Body fluid, Blood, Tissue, Pus, Stool
Analytical sensitivity10³ copies
Compatible instruments*ABI Veriti thermal Cycler (Applied Biosystems) recommended
PCR running time~ 2 hrs



Features

- HotStart PCR system : ultra high specific & sensitive result

- DnaFree™ system : No host genomic DNA contamination

- UDG system : No carryover contamination

- Multiplex PCR system : Multiple targets in a single reaction

- Reliable system : Automatic PCR control

- Positive control included

- Easy-to-use master mix

- CE certification





Experimental


LaneInterpretation (detection)
1Negative
2M. intracellulare
3M. avium
4M. intracellulare , M. avium (Co-infection)
5NTC
6Required re-experiment



Citation&Papers

The NTM handbook:

A Guide for Patients with Non-Tuberculous Mycobacterial Infections Including MAC.

Horsburgh CR Jr. Epidemiology of Mycobacterium avium complex.

In: Korvick JA, Benson CA, eds. Mycobacterium Avium Complex Infection: Progress in Research and Treatment. New York, NY: Marcel Dekker; 1996:1-22.

Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s.

Clin Microbiol Rev. 2003; 16:319-354.

Griffith, David, E.; Aksamit Timothy; & A. Brown-Elliott, Barbara et al. (2007).

American Thoracic Society Guidelines: Diagnosis, Treatment and Prevention of Non-tuberculous Mycobacterial Diseases. AM. J. Respiratory and Critical Care Medicine, Vol. 175, pp. 367-417.

Grange, J.M. (2007). “Environmental mycobacterial”. In Greenwood, David; Slack, Richard; peitherer, John; & Barer, Mike (Eds.),

Medical Microbiology (17th Ed.), pp. 221-227. Elsevier. ISBN 978-0-443-10209-7. Evans AJ, Crisp AJ, Hubbard RB, Colville A, Evans SA, Johnston IDA. Pulmonary Mycobacterium kansasii infection: comparision of radiological appearances with pulmonary tuberculosis. Thorax. 1996;51:1243-1247.





Ordering information

TechnologyCat. No.ProductContents
Conventional (End-point) PCRSMD23-K020 (20 reaction)DiaPlexC ™ M.Avium/M.Intracellulare Detection Kit2X Multiplex PCR Smart mix (with UDG)
(M.Av/M.Int)
Primer Mixture (M.Avium/M.Intra)
Standard Marker (M.Avium/M.Intra)
Control Template (M.Avium/M.Intra)
Nuclease free Water
SMD23-K100 (100 reaction)





More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry